Expert Perspectives on the Clinical Impact of Non-Medical Therapeutic Switching

home / insights / expert-perspectives-on-the-clinical-impact-of-non-medical-therapeutic-switching

Adam Friedman, MD, FAAD provides insight into how and why insurance companies implement non-medical therapeutic switching and what healthcare providers can do to mitigate its impact on patient care.

© 2024 MJH Life Sciences

All rights reserved.